TipRanks
Advertisement

QQQJ - ETF AI Analysis

Compare

Top Page

QQQJ

Invesco NASDAQ Next Gen 100 ETF (QQQJ)

Rating:68Neutral
Price Target:―
QQQJ, the Invesco NASDAQ Next Gen 100 ETF, earns a solid overall rating thanks to several strong holdings like NetApp, Credo Technology Group, and Okta, which bring robust financial performance, positive momentum, and promising AI and cloud growth themes to the portfolio. Additional contributors such as Flex, Illumina, eBay, and United Airlines support the rating with improving earnings and strategic initiatives, while weaker names like Revolution Medicines, with ongoing losses and bearish trends, slightly weigh on the fund. The main risk factor is exposure to high-valuation, growth-oriented tech and biotech companies, which can make the ETF more sensitive to market volatility and sector-specific downturns.
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered strong gains so far this year, showing solid recent momentum for investors.
Leading Holdings with Strong Gains
Several of the largest positions, including Flex, Revolution Medicines, and ON Semiconductor, have posted strong performance, helping drive the fund’s returns.
Broad Sector Diversification
Holdings spread across technology, health care, consumer, industrials, and other sectors help reduce the impact if any one industry runs into trouble.
Negative Factors
Heavy Tilt Toward U.S. Market
With the vast majority of assets in U.S. companies and only small exposure abroad, the fund is highly dependent on the U.S. economy and stock market.
Short-Term Performance Pullback
The ETF has slipped over the past month, showing that returns can be volatile even after a strong run this year.
Concentration in Growth-Oriented Sectors
A large allocation to technology and health care means the fund may be more sensitive to changes in investor sentiment toward growth stocks.

QQQJ vs. SPDR S&P 500 ETF (SPY)

QQQJ Summary

The Invesco NASDAQ Next Gen 100 ETF (QQQJ) tracks the Nasdaq Next Generation 100 Index, which focuses on mid-sized companies listed on the NASDAQ that sit just below the famous Nasdaq-100. It holds many fast-growing, innovation-focused businesses across technology, health care, and consumer sectors. Well-known names include eBay and United Airlines. Someone might invest in QQQJ to seek growth and diversify beyond the biggest tech giants, while still staying in innovative companies. A key risk is that these “next generation” stocks can be more volatile and can go up and down sharply with the overall stock market.
How much will it cost me?The Invesco NASDAQ Next Gen 100 ETF (QQQJ) has an expense ratio of 0.15%, which means you’ll pay $1.50 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, making it more cost-efficient compared to actively managed ETFs.
What would affect this ETF?The QQQJ ETF, with its strong focus on technology and healthcare sectors, could benefit from continued innovation and growth in these industries, especially as demand for cutting-edge tech and medical advancements rises. However, it may face challenges from regulatory changes in the tech and healthcare sectors or economic slowdowns that impact consumer spending and industrial activity, given its exposure to these areas. Additionally, interest rate hikes could negatively affect growth-oriented companies, which are a significant part of this ETF's portfolio.

QQQJ Top 10 Holdings

QQQJ is leaning into the “next wave” of U.S. innovators, with a clear tilt toward tech and health care. Rising names like Illumina, Natera, NetApp, and Okta are giving the fund a strong growth engine, helped by steady contributions from Biogen. On the flip side, Revolution Medicines’ more volatile biotech story and Credo Technology’s recent weakness have been holding performance back, while United Airlines has been more of a passenger than a driver. Overall, it’s a U.S.-centric bet on emerging tech and biotech leaders, with a few cyclical names for balance.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Natera2.99%$34.98M$59.47B152.48%
73
Outperform
eBay2.41%$28.15M$48.02B17.71%
70
Outperform
Revolution Medicines2.18%$25.49M$43.93B337.90%
52
Neutral
Flex2.10%$24.60M$42.36B96.42%
74
Outperform
Illumina2.07%$24.20M$40.77B195.96%
71
Outperform
NetApp2.02%$23.64M$39.51B72.40%
76
Outperform
Credo Technology Group Holding Ltd1.82%$21.34M$39.65B31.96%
77
Outperform
United Airlines Holdings1.82%$21.33M$37.00B13.05%
74
Outperform
Biogen1.70%$19.92M$33.63B65.10%
74
Outperform
Okta1.70%$19.92M$34.12B115.40%
75
Outperform

QQQJ Technical Analysis

Technical Analysis Sentiment
Negative
Last Price―
Price Trends
50DMA
44.78
Negative
100DMA
44.25
Negative
200DMA
41.14
Positive
Market Momentum
MACD
-0.23
Positive
RSI
42.71
Neutral
STOCH
38.08
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QQQJ, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 44.31, equal to the 50-day MA of 44.78, and equal to the 200-day MA of 41.14, indicating a neutral trend. The MACD of -0.23 indicates Positive momentum. The RSI at 42.71 is Neutral, neither overbought nor oversold. The STOCH value of 38.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for QQQJ.

QQQJ Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
――$1.17B0.15%
68
Neutral
――$9.94B0.34%
72
Outperform
――$9.84B0.39%
71
Outperform
――$8.97B0.12%
73
Outperform
――$8.90B0.31%
69
Neutral
――$8.79B0.06%
73
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
QQQJ
Invesco NASDAQ Next Gen 100 ETF
43.87
8.37
23.58%
PRF
Invesco FTSE RAFI US 1000 ETF
―
―
―
RWL
Invesco S&P 500 Revenue ETF
―
―
―
JQUA
JPMorgan U.S. Quality Factor ETF
―
―
―
TCAF
T. Rowe Price Capital Appreciation Equity ETF
―
―
―
VONE
Vanguard Russell 1000 ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement